KMV Narayana Rao appointed as Vice President - ARD at NATCO Research Centre
Hyderabad: Through a recent BSE filing, Natco Pharma has informed that K.M.V. Narayana Rao has been appointed as Vice President - ARD at NATCO Research Centre w.e.f. 12th June, 2024.
K.M.V. Narayana Rao has 28+ years of experience in Analytical R&D in APl's and NCE's, Key contributor to primary registration documents in GxP environment (CMC, IND, ANDA, CEP, DMF). He earlier worked as Associate Vice President (Head Analytical) at M/s. Aragen Life Sciences Private Limited (formerly GVKBIO) Hyderabad, India from 2015. He holds Ph.D (Analytical Chemistry) and M.Sc. Physical Chemistry from Andhra University, Visakhapatnam, India.
Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has eight manufacturing facilities spread across India with modern research laboratories, capabilities in New Drug Development, etc.
Read also: Natco Pharma invests around US$ 2 million in Cellogen Therapeutics
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.